Skip to main content
OpenTrials

Clinical trial condition

Gliosarcoma

Explore clinical trials studying Gliosarcoma. Study availability and eligibility vary by location and protocol.

373 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Gliosarcoma trial results

Completed

Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

NCT02311920

Conditions
Glioma, Gliosarcoma, Neoplasms, +7 more
Locations
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Completed

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

NCT01730950

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +19 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Oncology Services Foundation Phoenix, Arizona, United States
  • Arizona Oncology-Deer Valley Center Phoenix, Arizona, United States
  • John Muir Medical Center Walnut Creek, California, United States
View all 31 locations
View Trial Details
Completed

Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00731731

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +11 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • AdventHealth Orlando Orlando, Florida, United States
View all 110 locations
View Trial Details
Completed

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

NCT01062425

Conditions
Adult Glioblastoma, Adult Gliosarcoma, Astrocytoma, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Arizona Oncology Services Foundation Scottsdale, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 105 locations
View Trial Details
Completed

Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors

NCT01609790

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
Locations
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Anchorage Oncology Centre Anchorage, Alaska, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
View all 244 locations
View Trial Details
Completed

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT01062399

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
Locations
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • University of Florida Shands Cancer Center Gainesville, Florida, United States
  • Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States
  • Integrated Community Oncology Network at Southside Cancer Center Jacksonville, Florida, United States
View all 36 locations
View Trial Details
Completed

Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab

NCT02330562

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • University of Californai, Irvine Orange, California, United States
  • John Wayne Cancer Institute Santa Monica, California, United States
  • Weill Cornell Medical College New York, United States
  • Duke Univ Medical Center Durham, North Carolina, United States
View Trial Details

Related conditions